Dr. Charles Darragh, fellowship-trained Mohs surgeon, will be joining our team July 2018. Dr. Darragh is currently in fellowship at Vanderbilt Medical Center, where he also completed his dermatology residency. He received his Doctor of Medicine from the Medical University of South Carolina.
Mohs Micrographic Surgery is the most advanced and effective treatment procedure for skin cancer available today. The procedure is performed by our specially trained surgeon in our in-office operating suite. The benefit of Mohs surgery is that biopsies are completed on-site to determine whether they are cancerous and confirm that the surgeon has removed all of the diseased tissue. In many cases, Mohs surgery allows scarring to be minimized.
According to the ACMS, Mohs Micrographic Surgery is an effective and precise method for treating basal cell and squamous cell skin cancers. Because the Mohs Micrographic Surgery process features a systematic microscopic search that traces skin cancer down to its roots, it offers the highest chance for complete removal of the tumor while sparing the normal tissue surrounding it.
Clinical studies conducted at various national and international medical institutions, including the Mayo Clinic, the University of Miami School of Medicine and Royal Perth Hospital in Australia, demonstrate that Mohs surgery provides five-year cure rates exceeding 99 percent for new cancers, and 95 percent for recurrent cancers.